Pluri Inc. — Director's Dealing 2014

Jan 21, 2014

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person*
   BEN-YORAM ISRAEL 0001320556
   (Last) (First) (Middle)
   24 BARKAN STREET
   (Street)
   RISHON LEZION L3 75436
   (City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
   PLURISTEM THERAPEUTICS INC [ PSTI ]

3. Date of Earliest Transaction (Month/Day/Year)
   01/16/2014

4. If Amendment, Date of Original Filed (Month/Day/Year)

5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   X Director
   10% Owner
   Officer (give title below)
   Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)
   X Form filed by One Reporting Person
   Form filed by More than One Reporting Person

Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3)

Code	V	Amount (A or D)	Price
Common Stock	S	10,725	$4.507
Common Stock	S	24,900	$4.514

Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

1. Transaction Code (Instr. 8)

2. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

3. Date Exercisable and Expiration Date (Month/Day/Year)

4. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)

5. Price of Derivative Security (Instr. 5)

6. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

7. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)

8. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported on this Form 4 were affected pursuant to automatic selling under Rule 10b5-1 trading plan adopted by the reporting person.

Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.